Why Investors Are Flocking to the AbbVie Bond Sale

The transcript discusses the recent surge in bond market activity, highlighting a significant upsizing of deals due to high demand. Factors such as reduced issuance, tax changes, and high returns are driving this demand. The state of credit markets is strong, with both investment-grade and junk bonds seeing activity. Regulatory reviews are ongoing, but companies are taking advantage of favorable market conditions. AbbVie's financial metrics are under scrutiny due to increased debt, but investor trust remains due to the company's high cash flow.

What was the initial amount that was planned to be raised in the bond market?

What impact have tax changes had on bond issuance this year?

Why are investors currently flocking to high-quality bonds?

What is the significance of the current premium over Treasurys for investment-grade bonds?

How are companies like AbbVie managing their debt metrics in the current market?